A Human Ovarian Carcinoma Murine Xenograft Model Useful for Preclinical Trials

Xu, 1999, Characterization of human ovarian carcinomas in a SCID mouse model, Gynecol Oncol, 72, 161, 10.1006/gyno.1998.5238 Mattern, 1988, Human tumor xenografts as model for drug testing, Cancer Metast Rev, 7, 263, 10.1007/BF00047755 Hamilton, 1984, Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice, Cancer Res, 44, 5286 Ward, 1987, Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice, Cancer Res, 47, 2662 Massazza, 1989, Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy, Int J Cancer, 44, 494, 10.1002/ijc.2910440320 Fridman, 1991, Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with matrigel, J Natl Cancer Inst, 83, 769, 10.1093/jnci/83.11.769 Klein, 1997, Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice, Nature Med, 3, 402, 10.1038/nm0497-402 Karlan, 1999, Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening, Am J Obstet Gynecol, 180, 917, 10.1016/S0002-9378(99)70663-0 Saiki, 1985, Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia, Science, 230, 1350, 10.1126/science.2999980 Baldwin, 1999, Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis, Gynecol Oncol, 74, 265, 10.1006/gyno.1999.5448 Wills, 1994, Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer, Hum Gene Ther, 5, 1079, 10.1089/hum.1994.5.9-1079 Gurnani, 1999, Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer, Cancer Chemother Pharmacol, 44, 143, 10.1007/s002800050959 Noel, 1992, Basement membrane components (matrigel) promote the tumorigenicity of human breast adenocarinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen, Biochem Pharmacol, 43, 1263, 10.1016/0006-2952(92)90501-9 Phillips, 1988, Experimental correlations of in vitro drug sensitivity with in vivo responses to ThioTEPA in a panel of murine colon tumours, Cancer Chemother Pharmacol, 21, 168, 10.1007/BF00257366 Phillips, 1991, The relationship between the in vitro chemosensitivity of tumor cells and tumor response in vivo in an experimental tumor model, Int J Cell Cloning, 9, 144, 10.1002/stem.5530090205 Taghian, 1993, Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice, Cancer Res, 53, 5012 Reddy, 1987, Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency, Cancer Res, 47, 2456 Glas, 1995, Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex, Cancer Res, 55, 1911 Shpitz, 1994, Improved engraftment of human tumours in SCID mice pretreated with radiation and anti-asialo GM1, Anticancer Res, 14, 1927